Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Utkarsh J Dang

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Journal of Personalized Medicine|October 15, 2020
Comparison of Serum Pharmacodynamic Biomarkers in Prednisone-Versus Deflazacort-Treated Duchenne Muscular Dystrophy BoysShefa Tawalbeh, Alison Samsel, Heather Gordish-Dressman, et al.
BMC Rheumatology|October 5, 2020
Serum protein biomarkers for juvenile dermatomyositis: a pilot studyShefa M Tawalbeh, Wilfredo Marin, Gabrielle A Morgan, et al.
Human Molecular Genetics|June 28, 2020
Serum biomarkers associated with baseline clinical severity in young steroid-naïve Duchenne muscular dystrophy boysUtkarsh J Dang, Michael Ziemba, Paula R Clemens, et al.
Neurology. Genetics|September 3, 2025
Test-Retest Reliability of Motor Function and Myometry Outcomes From the Vamorolone Trials in Duchenne Muscular DystrophyRebecca A Tobin, Eric P Hoffman, Linda Johnson, et al.
Genetics|August 28, 2016
Estimation of Gene Insertion/Deletion Rates with Missing DataUtkarsh J Dang, Alison M Devault, Tatum D Mortimer, et al.
Journal of Neuromuscular Diseases|February 22, 2023
Modeling Early Heterogeneous Rates of Progression in Boys with Duchenne Muscular DystrophyYuan Fang, Craig M McDonald, Paula R Clemens, et al.
Psychoneuroendocrinology|October 11, 2023
A population-based study of children suggests blunted morning cortisol rhythms are associated with alterations of the systemic inflammatory stateRunia Roy, Utkarsh J Dang, Kim M Huffman, et al.
The Journal of Clinical Endocrinology and Metabolism|August 3, 2024
Adrenal Suppression From Vamorolone and Prednisone in Duchenne Muscular Dystrophy: Results From the Phase 2b Clinical TrialAlexandra Ahmet, Rebecca Tobin, Utkarsh J Dang, et al.
AAPS Pharmscitech|May 9, 2022
Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide DeliveryMengwei Sun, Utkarsh J Dang, Yuhao Yuan, et al.
Plos One|February 22, 2021
Biomarker-focused multi-drug combination therapy and repurposing trial in mdx miceMichael Ziemba, Molly Barkhouse, Kitipong Uaesoontrachoon, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Journal of Personalized Medicine|October 15, 2020
Comparison of Serum Pharmacodynamic Biomarkers in Prednisone-Versus Deflazacort-Treated Duchenne Muscular Dystrophy BoysShefa Tawalbeh, Alison Samsel, Heather Gordish-Dressman, et al.
BMC Rheumatology|October 5, 2020
Serum protein biomarkers for juvenile dermatomyositis: a pilot studyShefa M Tawalbeh, Wilfredo Marin, Gabrielle A Morgan, et al.
Human Molecular Genetics|June 28, 2020
Serum biomarkers associated with baseline clinical severity in young steroid-naïve Duchenne muscular dystrophy boysUtkarsh J Dang, Michael Ziemba, Paula R Clemens, et al.
Neurology. Genetics|September 3, 2025
Test-Retest Reliability of Motor Function and Myometry Outcomes From the Vamorolone Trials in Duchenne Muscular DystrophyRebecca A Tobin, Eric P Hoffman, Linda Johnson, et al.
Genetics|August 28, 2016
Estimation of Gene Insertion/Deletion Rates with Missing DataUtkarsh J Dang, Alison M Devault, Tatum D Mortimer, et al.
Journal of Neuromuscular Diseases|February 22, 2023
Modeling Early Heterogeneous Rates of Progression in Boys with Duchenne Muscular DystrophyYuan Fang, Craig M McDonald, Paula R Clemens, et al.
Psychoneuroendocrinology|October 11, 2023
A population-based study of children suggests blunted morning cortisol rhythms are associated with alterations of the systemic inflammatory stateRunia Roy, Utkarsh J Dang, Kim M Huffman, et al.
The Journal of Clinical Endocrinology and Metabolism|August 3, 2024
Adrenal Suppression From Vamorolone and Prednisone in Duchenne Muscular Dystrophy: Results From the Phase 2b Clinical TrialAlexandra Ahmet, Rebecca Tobin, Utkarsh J Dang, et al.
AAPS Pharmscitech|May 9, 2022
Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide DeliveryMengwei Sun, Utkarsh J Dang, Yuhao Yuan, et al.
Plos One|February 22, 2021
Biomarker-focused multi-drug combination therapy and repurposing trial in mdx miceMichael Ziemba, Molly Barkhouse, Kitipong Uaesoontrachoon, et al.
Pageof 4